Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence...
-
Upload
agnes-simpson -
Category
Documents
-
view
216 -
download
0
Transcript of Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence...
![Page 1: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/1.jpg)
Economic Analysis ofProposition 71:California Stem Cell Research and Cures Initiative
Laurence BakerAssociate Professor, Stanford University
Bruce DealManaging Partner, Analysis Group, Inc.
![Page 2: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/2.jpg)
22
Key FeaturesKey Features
Approximately $3 billion in funding for facilities and research on stem cells, committed over a 10 year period
Funded by bonds Payments deferred for 5 years Principal and interest paid back in years
6 through 35
![Page 3: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/3.jpg)
33
Costs and BenefitsCosts and Benefits
Costs: expense to State budget of paying back the bond principal and interest
Potential benefits: Tax receipts from new funded activity Tax receipts from incremental growth in
biotech sector Savings from development of new
therapies Royalty revenue
![Page 4: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/4.jpg)
44
Time StructureTime Structure
Year 1 5 10 15 20 25 30 35
FacilityCommitments1
$300m
Research Commitments1,2
$1.25b $1.4b
BondPayback
Int. Accum, No Principal Principal and Interest Repaid
Tax Rev from Institute funding
Tax Rev from new biotech
Health CareCost Reductions
Royalty Revenues
1. Amounts shown are approximate (and rounded)2. Includes administration and grant oversight costs of up to 6%
![Page 5: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/5.jpg)
55
Project DisbursementsProject Disbursements
Total:$2,986million
($ Millions)
Period of New Commitments
0
50
100
150
200
250
300
350
1 2 3 4 5 6 7 8 9 10 11 12 13 14
![Page 6: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/6.jpg)
66
Interest Rate AssumptionsInterest Rate Assumptions
Based on analysis of current market conditions, expert expectations, and adjustments for California-specific issues (e.g. lower bond rating)
Assume 3.0% interest rate in years 1-5 Assume 4.5% interest rate in years 6-35
![Page 7: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/7.jpg)
77
Bond RepaymentBond Repayment
$0$20$40$60$80
$100$120$140$160$180$200
0 5 10 15 20 25 30 35
InterestPrincipal
I: $56P: $0
I: $862P: $427
I: $1,450P: $2,560
Total, yrs 1-35Interest:
$2,368Principal:
$2,986Int+Prin: $5,355
($ Millions)
Accrued
![Page 8: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/8.jpg)
88
Tax Revenues From Initiative FundingTax Revenues From Initiative Funding
New funding will provide for expanded research and facility construction Initiative funds augmented by additional
matching funds, other research grants Some will be incremental, some not
Incremental activity has “multiplier effect” on overall economy
Total incremental economic activity produces new income and sales tax revenue for the State
![Page 9: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/9.jpg)
99
Tax Revenue EstimatesTax Revenue Estimates
0
5
10
15
20
25
30
35
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Total:$240
million
($ Millions)
Note: No tax revenue assumed in years 15-35 after Institute disbursements end
![Page 10: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/10.jpg)
1010
New Biotech ActivityNew Biotech Activity
California biotech industry already large 40% of U.S. biotech firms are in CA* 2003 “gross product” of $12 billion*
Proposition 71 could foster further growth Incremental growth would produce new
income and sales tax revenue for the state We investigate implications if California’s
life sciences sector were to be larger Scenario 1: 2.5% larger than baseline Scenario 2: 5% larger than baseline
* “California Life Sciences Action Plan: Taking Action for Tomorrow,” Bay Area Bioscience Center, BIOCOM, California Healthcare Institute,Southern California Biomedical Council, Bay Area Council, Larta Institute, Sacramento Regional Technology Alliance, and San Diego Area Regional Technology Alliance.
![Page 11: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/11.jpg)
1111
Biotech Industry SizeBiotech Industry Size
$0
$10,000
$20,000
$30,000
$40,000
$50,000
$60,000
$70,000
$80,000
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35
Baseline Scenario 1: 2.5% augment Scenario 2: 5% augment
($ Millions)
![Page 12: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/12.jpg)
1212
New Biotech Activity – Tax RevenueNew Biotech Activity – Tax Revenue
($ Millions)
Period 1
(Yrs 1-5)
Period 2
(Yrs 6-14)
Period 3
(Yrs 15-35) Total
Scenario 1 $54 $355 $1,796 $2,206
Scenario 2 $108 $711 $3,592 $4,411
![Page 13: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/13.jpg)
1313
Health Care Cost SavingsHealth Care Cost Savings
Stem cell therapies could reduce the costs of treating many health conditions
If successful therapies are developed (or even just developed sooner) under Proposition 71, health care costs could be reduced
The State pays health care costs for Medicaid, state employees, and others, so State costs could also be reduced
We investigate the implications of reductions in State government and overall costs for 6 conditions
![Page 14: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/14.jpg)
1414
Six ConditionsSix Conditions
Type I Diabetes Heart Attack (AMI) Stroke Parkinson’s Disease Spinal Cord Injury Alzheimer’s Disease
![Page 15: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/15.jpg)
1515
Three Types of CostsThree Types of Costs
Direct medical costs for the under 65 population Based on data from a large insured population
Lost work costs in the 19-65 population Based on data from large insured population
Nursing home costs (for all ages)
![Page 16: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/16.jpg)
1616
Three Savings ScenariosThree Savings Scenarios
Scenario 1: Limited success Model as a 1% reduction in costs for the
6 conditions in years 5-15 through 35 Scenario 2: Increased success
2% reduction for 6 conditions in years 5-15 through 35
Scenario 3: Expanded Success 10% reduction for 6 conditions in years
5-15 through 35
![Page 17: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/17.jpg)
1717
Annual Direct and Lost Work Cost Reductions, Annual Direct and Lost Work Cost Reductions, State BudgetState Budget
$0
$200
$400
$600
$800
$1,000
$1,200
$1,400
$1,600
1 3 5 7 9 11 1315 17 19 2123 25 27 2931 33 35
Scenario 1 Scenario 2 Scenario 3
($ Millions) Total, yr 1-35S1: $2,244S2: $4,487S3: $22,435
![Page 18: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/18.jpg)
1818
Medicaid Nursing Home Cost Reductions, Medicaid Nursing Home Cost Reductions, State BudgetState Budget
$0
$100
$200
$300
$400
$500
$600
$700
$800
$900
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35
Scenario 1 Scenario 2 Scenario 3
Total, yr 1-35S1: $1,200S2: $2,400S3: $12,002
($ Millions)
![Page 19: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/19.jpg)
1919
Total State Budget Health Care Cost ReductionsTotal State Budget Health Care Cost Reductions
Scenario 1 $3,444
Scenario 2 $6,887
Scenario 3 $34,437
($ Millions)
![Page 20: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/20.jpg)
2020
Royalty RevenuesRoyalty Revenues
Proposition 71 includes provisions for the state to share in ownership of intellectual property developed with Initiative funds
New discoveries could be licensable, and bring in royalty revenues to the state
We investigate implications of the state receiving royalties from 3-4 new therapies, with 7 year patent lifetimes, using revenue projections based on current therapies Scenario 1: 2% royalty rate Scenario 2: 4% royalty rate
![Page 21: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/21.jpg)
2121
Annual Royalty Revenues, 2% Royalty RateAnnual Royalty Revenues, 2% Royalty Rate
$0
$10
$20
$30
$40
$50
$60
1 3 5 7 9 11 1315 171921 2325 272931 3335
TotalYrs 1-35$537
($ Millions)
![Page 22: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/22.jpg)
2222
Combined ResultsCombined Results
We combine results in 3 cases
Case 1
2.5% biotech increase 1% health care cost savings 2% royalty rate
Case 2
5% biotech increase 2% health care cost savings 4% royalty rate
Case 3
5% biotech increase 10% health care cost savings 4% royalty rate
![Page 23: Economic Analysis of Proposition 71: California Stem Cell Research and Cures Initiative Laurence Baker Associate Professor, Stanford University Bruce Deal.](https://reader035.fdocuments.net/reader035/viewer/2022062517/56649ecf5503460f94bdcc49/html5/thumbnails/23.jpg)
2323
Combined ResultsCombined Results
Total, Year 1-35 % of State costs
Cost to State Budget $5,355 ---
Benefits to State Budget
Case 1 $6,426 120%
Case 2 $12,612 236%
Case 3 $40,161 750%
Additional HC Benefits to Californians
Case 1 $9,180 171%
Case 2 $18,359 343%
Case 3 $91,797 1714%
Summary